Study to Evaluate Safety and Pharmacokinetics of ARRY-403 in Patients With Type 2 Diabetes



Status:Archived
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:August 2009

Use our guide to learn which trials are right for you!

A Randomized, Double-Blind (Sponsor Excepted), Placebo-Controlled Multiple Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Orally Administered ARRY-403 in Patients With Type 2 Diabetes


Phase 1 study is designed to evaluate the safety, pharmacokinetics (PK) and pharmacodynamics
(PD) of multiple ascending doses of ARRY-403 provided to patients with type 2 diabetes. The
study will consist of a Screening period, a Diary and Glucometer Dispensing Visit, a Washout
Period, a Confinement Period in the Clinical Research Unit, and a Follow-up/Termination
Visit.



We found this trial at
2
sites
Chula Vista, California 91911
115
mi
from 91732
Chula Vista, CA
Click here to add this to my saved trials
Fargo, North Dakota 58104
1411
mi
from 91732
Fargo, ND
Click here to add this to my saved trials